Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11.05.11 |
Kirk Look
DFI | Director of Finance/CFO | - | 01.04.03 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01.08.20 |
Jon Patton
IRC | Investor Relations Contact | - | 01.08.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07.09.22 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09.01. |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08.06.15 |
James Parsons
BRD | Director/Board Member | 58 | 16.06.22 |
Angela Holtham
BRD | Director/Board Member | 73 | 18.06.14 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11.05.11 |
Wayne Pisano
CHM | Chairman | 69 | 09.05.13 |
Deborah Brown
BRD | Director/Board Member | - | 02.11.17 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 75 419 768 | 70 774 786 ( 93,84 %) | 0 | 93,84 % |
Unternehmenskontakt
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSektor
% 1. Jan. | Kap. | |
---|---|---|
-1,82 % | 41,35 Mrd. | |
+43,06 % | 40,38 Mrd. | |
+2,56 % | 39,05 Mrd. | |
-12,11 % | 26,67 Mrd. | |
+3,09 % | 24,07 Mrd. | |
-24,16 % | 18,36 Mrd. | |
+22,12 % | 11,6 Mrd. | |
-3,74 % | 11,68 Mrd. | |
+7,75 % | 11,15 Mrd. |